Stay updated with breaking news from Development Partnership. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gonorrhoea is the second most common bacterial STI in the UK after chlamydia, however, it has developed a resistance to all antibiotic treatments except one.
So-called ‘super gonorrhoea’ could have finally met its match in a brand new antibiotic – the first new treatment in decades for the STI.
In today's Research Roundup for November 6, 2023, we highlight some of the most interesting reads in global health research and development from the past week.
Discover the latest breakthrough in STI treatment as zoliflodacin, a new antibiotic, shows effectiveness against drug-resistant gonorrhea in clinical trials.
WINDSOR —<strong> </strong>Multiple economic developers, their agencies and area organizations were recognized as part of this year’s EDIE Awards — a recognition program offered through the the Economic Development Council of Colorado.